Skip to main content

Home/ Cerebral Palsy/ Group items tagged PPI

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Lee Vander Loop

Non-interventional Study to Evaluate the Change in Symptoms Scores and Treatment Respon... - 0 views

www.clinicaltrials.gov/...NCT01103804

gastroesophageal reflux clinical trial clinical trials gastroesophageal reflux disease study GERD reflux

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Objective of the study is to describe the change in GerdQ sum scores, after a 4-week period of systematic treatment with PPIs(using GerdQ questionnaire). The secondary objectives are: to measure the response at the current treatment after a 4-week period of systematic treatment and to identify the percentage of patients which require alterations of their treatment (GerdQ questionnaire)"
Lee Vander Loop

To Evaluate the Safety and Efficacy of Rabeprazole in Infants With Gastroesophageal Ero... - 0 views

www.clinicaltrials.gov/...NCT00992589

gastroesophageal reflux clinical trial clinical trials gastroesophageal reflux disease protein pump inhibitor reflux GERD study Rabeprazole PPI

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Purpose of this study is to assess the effectiveness and safety of rabeprazole sodium, an inhibitor of gastric acid secretion of the protein pump inhibitor (PPI) class, compared with placebo in the treatment of gastrointestinal esophageal reflux disease (GERD) in infants 1 to 11 months of age.
Lee Vander Loop

Evaluation of the Safety and Effectiveness of Tailored Transoral Incisionless Fundoplic... - 0 views

www.clinicaltrials.gov/...NCT01025739

clinical trials clinical trial nissan fundoplication incisionless fundoplication gastroesophageal relux GERD fundoplication TIF Esophyx reflux research study

shared by Lee Vander Loop on 16 May 10 - Cached
  • Lee Vander Loop on 16 May 10
     
    Future planned study with the objective of evaluating the relative merits, safety and effectiveness of the tailored TIF2 procedure in treating GERD patients who have persistent GERD symptoms despite PPI therapy.The secondary objective of the study is to evaluate the effectiveness of the tailored TIF procedure in restoring the antireflux barrier and eliminating gastroesophageal reflux.
Lee Vander Loop

Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Ga... - 0 views

www.clinicaltrials.gov/...NCT00365300

gastroesophageal reflux disease gastroesophageal reflux clinical trials antacids and neonates GERD reflux PPI Pantoprazole

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Study to assess the efficacy of pantoprazole for the treatment of infants with symptomatic Gastroesophageal Reflux Disease (GERD)
Lee Vander Loop

A Pharmacokinetics (Blood Levels), Pharmacodynamics (How the Drug Acts on the Body) and... - 0 views

www.clinicaltrials.gov/...NCT00855361

gastroesophageal reflux disease gastroesophageal reflux antacids and neonates clinical trials safety reflux GERD antacids PPI pharmacokinetics Rabeprazole

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Study is to evaluate the pharmacokinetics (blood levels), pharmacodynamics (how the drug acts on the body), and the safety of rabeprazole sodium for the treatment of gastroesophageal reflux disease (GERD) in new borns and pre-term infants (less than 44 weeks of age).
Lee Vander Loop

Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than... - 0 views

www.clinicaltrials.gov/...NCT00868296

gastroesophageal reflux gastroesophageal reflux disease clinical trials antacids and neonates reflux GERD antacids PPI study safety pantoprazole pantoprazole in infants

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Purpose of this completed study is to provide additional information on safety and tolerability after multiple doses of pantoprazole in infants
Lee Vander Loop

Proton Pump Inhibitor Therapy and Bone Density in Premature Infants - 0 views

www.clinicaltrials.gov/...NCT00888017

gastroesophageal reflux protein pump inhibitor gastroesophageal reflux disease antacids and neonates antacid contradiction in neonates clinical trial clinical trials reflux GERD antacids PPI

shared by Lee Vander Loop on 06 May 10 - Cached
  • Lee Vander Loop on 06 May 10
     
    Objective is to determine if a connection exists between proton pump inhibitor antacids and decreased rate of bone mineralization in neonates
1 - 7 of 7
Showing 20▼ items per page